secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001558370-23-007832
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q1 net sales rise 9% to $73.9M; guides 2023 sales up; GAAP net loss widens to $34.6M
--------------------------------------------------------------------------------

- Q1 2023 net sales $73.9M (+9% YoY); glaucoma $56.2M (+9%), corneal health $17.7M (+10%).
- GAAP net loss $34.6M ($0.72 loss per share) vs net income $5.4M ($0.11) in Q1 2022.
- Non-GAAP net loss $28.4M ($0.59) vs prior-year non-GAAP net loss $18.1M ($0.38).
- Raised 2023 net sales guidance to $295-300M from $290-295M.
- Operating expenses increased sharply: SG&A +22%, R&D +31%; ended Q1 with $325M cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023007832/0001558370-23-007832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023007832/gkos-20230503x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-007832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer